A Retrospective Study Evaluating Safety And Efficacy Of Zoledronic Acid In The Treatment Of Patients With Bone Loss After Hematopoietic Stem Cell Transplantation.
Phase of Trial: Phase IV
Latest Information Update: 20 Jan 2017
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Metabolic bone diseases; Osteopetrosis
- Focus Adverse reactions; Therapeutic Use
- 20 Jan 2017 New trial record
- 06 Dec 2016 Results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.